BAMCO Inc’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-20,470
Closed -$2.5M 339
2016
Q4
$2.5M Sell
20,470
-23,790
-54% -$2.91M 0.01% 241
2016
Q3
$5.42M Sell
44,260
-17,989
-29% -$2.32M 0.03% 212
2016
Q2
$7.27M Buy
62,249
+6,299
+11% +$894K 0.04% 197
2016
Q1
$7.79M Sell
55,950
-5,227
-9% -$767K 0.04% 199
2015
Q4
$11.7M Buy
61,177
+28,553
+88% +$4.99M 0.05% 206
2015
Q3
$5.1M Sell
32,624
-37,140
-53% -$6.77M 0.02% 241
2015
Q2
$12.6M Buy
69,764
+28,601
+69% +$4.94M 0.05% 229
2015
Q1
$7.13M Buy
41,163
+22,797
+124% +$4.13M 0.03% 255
2014
Q4
$3.4M Buy
18,366
+5,425
+42% +$1.01M 0.01% 274
2014
Q3
$2.15M Buy
12,941
+2,796
+28% +$459K 0.01% 289
2014
Q2
$1.58M Sell
10,145
-73
-0.7% -$11.5K 0.01% 297
2014
Q1
$1.55M Buy
+10,218
New +$1.62M 0.01% 293

Other funds holding ALXN